Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies

por Smith, Tyler E, Madhavan, Maya, Gratch, Daniel, Patel, Aneek, Saha, Valerie, Sammarco, Carrie, Rimler, Zoe, Zuniga, Guadalupe, Gragui, Dunia, Charvet, Leigh, Cutter, Gary, Krupp, Lauren, Kister, Ilya, Ryerson, Lana Zhovtis
Publicado 2022

COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center

por Parrotta, Erica, Kister, Ilya, Charvet, Leigh, Sammarco, Carrie, Saha, Valerie, Charlson, Robert Erik, Howard, Jonathan, Gutman, Josef Maxwell, Gottesman, Malcolm, Abou-Fayssal, Nada, Wolintz, Robyn, Keilson, Marshall, Fernandez-Carbonell, Cristina, Krupp, Lauren B., Zhovtis Ryerson, Lana
Publicado 2020